CR
CRVL.US CorVel Corp
- Market cap
- USD 4.31B
- P/E
- 36.0x
- P/B
- 10.12x
- ROE
- 30.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is CRVL.US undervalued?
Graham numberThe Graham number of CorVel Corp cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CorVel Corp fundamental analysis
No fundamental analysis for CorVel Corp yet.
CorVel Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CorVel Corp
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospect…
Full company profileCorVel Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CorVel Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 519M | 558M | 596M | 592M | 553M | 646M | 719M | 795M | 896M | 959M | 1.05B |
| Gross Profit | 105M | 107M | 125M | 126M | 124M | 152M | 158M | 172M | 210M | 233M | 263M |
| Operating Income | 47.5M | 47.9M | 61.5M | 60.7M | 59.2M | 84.5M | 84.6M | 95.1M | 121M | 143M | 178M |
| EBITDA | 68.5M | 69.7M | 84.5M | 83.2M | 82.6M | 108M | 110M | 121M | 150M | 175M | 196M |
| Net Income | 29.5M | 35.7M | 46.7M | 47.4M | 46.4M | 66.4M | 66.4M | 76.3M | 95.2M | 110M | 133M |
| EPS | 1.51 | 1.87 | 2.46 | 2.56 | 2.50 | 1.22 | 1.26 | 1.47 | 1.83 | 2.14 | 2.62 |
| Balance Sheet | |||||||||||
| Total Assets | 235M | 274M | 318M | 416M | 425M | 415M | 394M | 455M | 546M | 643M | 714M |
| Total Liabilities | 96.7M | 103M | 123M | 227M | 204M | 203M | 192M | 207M | 224M | 249M | 283M |
| Shareholders' Equity | 139M | 171M | 195M | 190M | 220M | 212M | 202M | 248M | 322M | 394M | 431M |
| Cash & Short-term Investments | 28.6M | 55.8M | 91.7M | 83.2M | 140M | 97.5M | 71.3M | 106M | 171M | 233M | 270M |
| Total Debt | - | - | - | 98.3M | 54.7M | 43.1M | 33.8M | 31.4M | 28.1M | 28.1M | 33.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 52.1M | 62.2M | 78.6M | 80.8M | 94.4M | 67.2M | 82.3M | 99.2M | 127M | 156M | 179M |
| Capital Expenditure | 31.0M | 27.7M | 15.3M | 32.4M | 17.2M | 29.8M | 26.3M | 29.2M | 35.8M | 45.4M | 34.3M |
| Free Cash Flow | 21.0M | 34.5M | 63.4M | 48.5M | 77.1M | 37.4M | 56.0M | 70.0M | 91.6M | 110M | 145M |
| Ratios | |||||||||||
| ROE | 21.3% | 20.9% | 24.0% | 25.0% | 21.0% | 31.3% | 32.8% | 30.8% | 29.6% | 28.0% | 30.8% |
| ROA | 12.5% | 13.0% | 14.7% | 11.4% | 10.9% | 16.0% | 16.8% | 16.8% | 17.4% | 17.2% | 18.6% |
| Net Profit Margin | 5.7% | 6.4% | 7.8% | 8.0% | 8.4% | 10.3% | 9.2% | 9.6% | 10.6% | 11.5% | 12.6% |
| Debt to Equity | - | - | - | 0.52x | 0.25x | 0.20x | 0.17x | 0.13x | 0.09x | 0.07x | 0.08x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CorVel Corp dividends
CorVel Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 3:1 on Dec 26, 2024.
Who owns CorVel Corp
- Insiders 39.03%
- Institutions 56.50%
- Public & others 4.47%
- Shares outstanding 50.3M
- Free float 30.7M
Top funds holding CRVL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1.86M | 3.68% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 899K | 1.78% | +0.53% | Sep 2026 |
| Virtus KAR Small-Cap Core I | 788K | 1.56% | -10.76% | Jun 2026 |
| iShares Russell 2000 ETF | 748K | 1.48% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 626K | 1.24% | -2.26% | Sep 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 348K | 0.69% | -5.23% | Sep 2026 |
| Fidelity Small Cap Index | 323K | 0.64% | +0.13% | Aug 2026 |
| DFA U.S. Small Cap I | 314K | 0.62% | -5.39% | Sep 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 282K | 0.56% | -0.05% | Oct 2026 |
| iShares Russell 2000 Growth ETF | 277K | 0.55% | -0.38% | Oct 2026 |
| Vanguard Tax-Managed Small Cap Adm | 185K | 0.37% | 0.00% | Sep 2026 |
| DFA US Micro Cap I | 179K | 0.35% | 0.00% | Sep 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 173K | 0.34% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 172K | 0.34% | +1.18% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 164K | 0.33% | +0.23% | Oct 2026 |
| Dimensional US Small Cap ETF | 154K | 0.31% | 0.00% | Oct 2026 |
| Fidelity Extended Market Index | 142K | 0.28% | -7.56% | Sep 2026 |
| Boston Trust Walden Small Cap | 137K | 0.27% | -1.66% | Sep 2026 |
| Strategic Advisers Fidelity US TtlStk | 120K | 0.24% | +4.55% | Sep 2026 |
| Vanguard S&P Small-Cap 600 ETF | 109K | 0.22% | -2.93% | Sep 2026 |
Top institutions holding CRVL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 5.14M | 10.17% | +5.38% | Jun 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 4.55M | 9.01% | -6.57% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 1.72M | 3.40% | +1.68% | Jun 2026 |
| Renaissance Technologies Corp | 1.53M | 3.03% | -5.46% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.30M | 2.57% | +0.10% | Jun 2026 |
| State Street Corp | 1.29M | 2.55% | +6.62% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.15M | 2.27% | +0.91% | Sep 2026 |
| Geode Capital Management, LLC | 1.01M | 2.01% | +8.11% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 656K | 1.30% | -5.64% | Jun 2026 |
| Wells Fargo & Co | 453K | 0.90% | -1.90% | Jun 2026 |
| Northern Trust Corp | 410K | 0.81% | +8.12% | Jun 2026 |
| Owls Nest Partners IA, LLC | 408K | 0.81% | +17.04% | Jun 2026 |
| BTIM Corp | 395K | 0.78% | -4.83% | Sep 2026 |
| Algert Global LLC | 383K | 0.76% | +67.04% | Jun 2026 |
| AQR Capital Management LLC | 359K | 0.71% | +176.07% | Jun 2026 |
| Charles Schwab Investment Management Inc | 313K | 0.62% | +13.15% | Jun 2026 |
| The Goldman Sachs Group Inc | 252K | 0.50% | +29.29% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 222K | 0.44% | +35.33% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 219K | 0.43% | +3.16% | Jun 2026 |
| Assenagon Asset Management SA | 204K | 0.40% | +3.06% | Jun 2026 |
CorVel Corp company profile
- Company name
- CorVel Corp
- Ticker
- CRVL.US
- Exchange
- USA Stocks
- Listed since
- Jun 28, 1991
- Sector
- Financial Services
- Industry
- Health Care Providers & Services
- Employees
- 5,239
- Fiscal year end
- March
- Address
- 5128 Apache Plume Road, Fort Worth, TX, United States, 76109
- Phone
- 817 390 1416
- Website
- corvel.com
About CorVel Corp
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
CorVel Corp management
10- Mr. Michael G. CombsExecutive Chair · born 1964
- Mr. Brian S. NicholsChief Financial Officer · born 1981
- Ms. Jennifer L. YossVice President of Accounting · born 1978
- Mr. Maxim ShishinChief Information Officer · born 1975
- Mr. Mark E. BertelsExecutive Vice President of Risk Management Services · born 1963
- Ms. Sarah ScottPresident & CEO · born 1977
- Ms. Sharon F. O'ConnorVice President of Legal Services
- Melissa StoranVice President of Marketing
- Jason WheelerVice President of Sales & Account Management
- Mr. Jeffrey D. GurtcheffChief Claims Officer